Case Studies
Creative recruiting strategies result in over-enrollment in a limited population for a phase II study.
Acute Macular Degeneration
Collaborative relationship and experienced leadership achieve targeted interim analysis date in an exceptionally short time frame with Sponsor outsourcing additional data management activities during this phase III study.
Autoimmune Disorder
Creative strategies and collaborative partnerships result in accelerating the original timeline and beating enrollment goals for a potential cost savings of $7.5 million.
Contingency planning and strong site relationships allow study to meet original timelines, in spite of mid-stream client changes for a phase IV study.
Oncology
Communication, training, and team continuity result in bringing two lagging Phase III oncology pain studies back on track and allow the sponsor to file their NDA within an acceptable timeframe.
Pulmonary Arterial Hypertension
Creativity results in reduced enrollment timeline from previous large incumbent CRO by 15 months for a phase III study.
Foresight and global experience reduce the enrollment timeline for a phase II study by two months in spite of challenges due to H1N1.
Transdermal Iontophoretic Delivery System
Superior team communication and a true collaborative partnership result in a 13% savings on labor and a query rate of only 4.5%.
